USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF FIBROSIS USING EMT INHIBITORY ACTIVITY
申请人:OSTEONEUROGEN INC.
公开号:US20170239211A1
公开(公告)日:2017-08-24
A pharmaceutical composition contains the chromone derivative of Chemical Formula 1 and a pharmaceutically acceptable salt as an active ingredient, thus effectively inhibiting the activation of EMT to thereby enable the effective suppression of a disease caused by fibrosis of an organ or tissue in vivo due to the activation of EMT.
一种药物组合物包含
化学式1的咖啡酮衍
生物和一种药用可接受的盐作为活性成分,从而有效抑制
EMT的激活,从而使得能够有效抑制由于
EMT激活而导致的器官或组织纤维化引起的疾病。